Credit Suisse’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.64M | Sell |
134,182
-174
| -0.1% | -$4.87K | ﹤0.01% | 1477 |
|
|
2023
Q4 | $4.16M | Sell |
134,356
-343
| -0.3% | -$8.89K | ﹤0.01% | 1438 |
|
|
2023
Q3 | $3.4M | Sell |
134,699
-15,871
| -11% | -$363K | ﹤0.01% | 1508 |
|
|
2023
Q2 | $3.18M | Buy |
150,570
+32,639
| +28% | +$619K | ﹤0.01% | 1629 |
|
|
2023
Q1 | $2.01M | Buy |
117,931
+2,330
| +2% | +$45.3K | ﹤0.01% | 1862 |
|
|
2022
Q4 | $2.31M | Buy |
115,601
+10,746
| +10% | +$208K | ﹤0.01% | 1787 |
|
|
2022
Q3 | $2.26M | Buy |
104,855
+3,409
| +3% | +$81.7K | ﹤0.01% | 1779 |
|
|
2022
Q2 | $2M | Sell |
101,446
-4,015
| -4% | -$84.1K | ﹤0.01% | 1914 |
|
|
2022
Q1 | $2.48M | Buy |
105,461
+12,665
| +14% | +$294K | ﹤0.01% | 1938 |
|
|
2021
Q4 | $2.53M | Sell |
92,796
-49,227
| -35% | -$1.41M | ﹤0.01% | 2610 |
|
|
2021
Q3 | $3.91M | Buy |
142,023
+63,895
| +82% | +$1.68M | ﹤0.01% | 2257 |
|
|
2021
Q2 | $2.22M | Buy |
78,128
+19
| +0% | +$564 | ﹤0.01% | 2781 |
|
|
2021
Q1 | $2.66M | Sell |
78,109
-68,971
| -47% | -$2.64M | ﹤0.01% | 2598 |
|
|
2020
Q4 | $4.9M | Buy |
147,080
+29,709
| +25% | +$1.09M | ﹤0.01% | 2106 |
|
|
2020
Q3 | $3.77M | Sell |
117,371
-41,269
| -26% | -$1.19M | ﹤0.01% | 1976 |
|
|
2020
Q2 | $4.37M | Buy |
158,640
+42,036
| +36% | +$997K | ﹤0.01% | 1788 |
|
|
2020
Q1 | $1.87M | Buy |
116,604
+40,101
| +52% | +$951K | ﹤0.01% | 2185 |
|
|
2019
Q4 | $1.83M | Sell |
76,503
-618,182
| -89% | -$12.6M | ﹤0.01% | 2678 |
|
|
2019
Q3 | $12.3M | Buy |
694,685
+609,926
| +720% | +$11.8M | 0.01% | 1191 |
|
|
2019
Q2 | $2.17M | Buy |
84,759
+22,089
| +35% | +$615K | ﹤0.01% | 2401 |
|
|
2019
Q1 | $1.82M | Buy |
62,670
+6,213
| +11% | +$161K | ﹤0.01% | 2446 |
|
|
2018
Q4 | $742K | Buy |
56,457
+14,929
| +36% | +$238K | ﹤0.01% | 3015 |
|
|
2018
Q3 | $840K | Sell |
41,528
-23,691
| -36% | -$535K | ﹤0.01% | 2991 |
|
|
2018
Q2 | $1.54M | Sell |
65,219
-16,934
| -21% | -$436K | ﹤0.01% | 2681 |
|
|
2018
Q1 | $1.85M | Buy |
82,153
+19,066
| +30% | +$502K | ﹤0.01% | 2488 |
|
|
2017
Q4 | $1.97M | Sell |
63,087
-19,793
| -24% | -$585K | ﹤0.01% | 2446 |
|
|
2017
Q3 | $2.59M | Sell |
82,880
-3,792
| -4% | -$72.2K | ﹤0.01% | 2323 |
|
|
2017
Q2 | $1.49M | Buy |
86,672
+14,273
| +20% | +$244K | ﹤0.01% | 2424 |
|
|
2017
Q1 | $1.27M | Buy |
72,399
+8,089
| +13% | +$125K | ﹤0.01% | 2675 |
|
|
2016
Q4 | $851K | Sell |
64,310
-55,972
| -47% | -$764K | ﹤0.01% | 3136 |
|
|
2016
Q3 | $1.75M | Buy |
120,282
+21,584
| +22% | +$270K | ﹤0.01% | 2480 |
|
|
2016
Q2 | $973K | Buy |
98,698
+36,594
| +59% | +$427K | ﹤0.01% | 2949 |
|
|
2016
Q1 | $786K | Buy |
62,104
+14,914
| +32% | +$196K | ﹤0.01% | 2908 |
|
|
2015
Q4 | $856K | Buy |
47,190
+13,469
| +40% | +$237K | ﹤0.01% | 2947 |
|
|
2015
Q3 | $626K | Sell |
33,721
-90,997
| -73% | -$2.27M | ﹤0.01% | 3231 |
|
|
2015
Q2 | $3.05M | Buy |
124,718
+67,155
| +117% | +$1.52M | ﹤0.01% | 2200 |
|
|
2015
Q1 | $1.2M | Buy |
57,563
+1,611
| +3% | +$28.4K | ﹤0.01% | 2824 |
|
|
2014
Q4 | $865K | Buy |
55,952
+36,141
| +182% | +$513K | ﹤0.01% | 3261 |
|
|
2014
Q3 | $259K | Sell |
19,811
-6,632
| -25% | -$100K | ﹤0.01% | 4008 |
|
|
2014
Q2 | $528K | Sell |
26,443
-9,652
| -27% | -$143K | ﹤0.01% | 3790 |
|
|
2014
Q1 | $687K | Sell |
36,095
-11,824
| -25% | -$225K | ﹤0.01% | 3467 |
|
|
2013
Q4 | $814K | Sell |
47,919
-4,520
| -9% | -$69.2K | ﹤0.01% | 3442 |
|
|
2013
Q3 | $818K | Buy |
+52,439
| New | +$666K | ﹤0.01% | 3121 |
|
Other funds holding INSM
DTC
PAI
Credit Suisse's INSM Position: Q1 2024 in Review
Credit Suisse reduced its Insmed (INSM) stake by 0.13% in Q1 2024, selling an estimated $4.87K and leaving 134,182 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.
Credit Suisse first reported a position in INSM in Q3 2013 and has held it in 43 quarters since. The position peaked at $12.3M in Q3 2019. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.
- Credit Suisse held 134,182 shares of Insmed worth $3.64M as of Q1 2024.
- Credit Suisse sold 174 Insmed shares in Q1 2024, an estimated $4.87K.
- Insmed made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1477 holding.
- Credit Suisse first reported a position in Insmed in Q3 2013 and has held it in 43 quarters since.
- Credit Suisse's Insmed position peaked at $12.3M in Q3 2019.
- 288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.